Vivos Therapeutics (VVOS) Stock: Buy, Sell, or Hold?
VVOS - Vivos Therapeutics, Inc. Common Stock
$0.18
0.00 (1.32%)
▲
5d:
+5.38%
30d:
-35.66%
90d:
-70.02%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 18, 2026
0d
Get Alerted When VVOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: VVOS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: VVOS shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: VVOS is currently trading at $0.18, which is considered oversold relative to its 30-day fair value range of $0.19 to $0.34.
Technical Outlook: Technically, VVOS is in a strong downtrend. Immediate support is located at $0.16, while resistance sits at $0.46.
Market Sentiment: VVOS scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.12 (+1050.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VVOS is in a strong downtrend. Immediate support is located at $0.16, while resistance sits at $0.46.
Market Sentiment: VVOS scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.12 (+1050.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.19 -
$0.34
Company Quality Score
51/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: Trading 1050.4% below Wall St target ($2.12)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.19 -
$0.34
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.16
Resistance Level
$0.46
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.22
Wall Street Target
$2.12
(+1050.4%)
Revenue Growth (YoY)
34.9%
Profit Margin
-121.8%
Share & Embed Analysis
Last updated: September 11, 2026 11:32 PM ET
Data refreshes hourly during market hours. Next update: 12:32 AM
Data refreshes hourly during market hours. Next update: 12:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VVOS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Michael C Skaff
BUY
1353625 shares
2026-03-31
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
